Featured Experience
PTAB Trials: IPRs, PGRs, DERs
Sterne Kessler’s PTAB Trials team is deeply experienced in all proceedings at the PTAB, including inter partes reviews (IPRs), post-grant reviews (PGRs), and derivation proceedings (DERs). We emerged as a leader at the inception of the PTAB, and continue to be a dominant force in the industry today. We are among the top 10 most active firms at the PTAB, representing petitioners and patent owners across all technologies, including biotechnology, electronics, consumer products, automotive, and many others.
Artificial Intelligence
In the rapidly evolving world of artificial intelligence (AI), safeguarding your intellectual property (IP) is critical. As a market and thought leader in the technology sector, Sterne Kessler helps clients develop comprehensive IP solutions that protect innovation, foster growth, and maximize value. Whether you are an emerging startup company or a well-established technology pioneer, we are committed to helping you harness the full potential of AI technology.
Pharmaceutical Patent Litigation
At Sterne Kessler, we know what it takes to win across any venue in pharmaceutical IP litigation. Our award-winning team has a deep bench of experienced litigators representing biosimilars as well as generic and specialty brand pharmaceutical companies in high-profile patent litigation, including blockbuster Abbreviated New Drug Application (ANDA) and Biologics Price Competition and Innovation Act (BPCIA) matters.
ITC Litigation
With one of the nation’s top ITC practices, Sterne Kessler offers unrivaled experience, comprehensive litigation strategy, and the legal and technical know-how to achieve the best possible results. In the last five years, Sterne Kessler has handled more cases at the ITC than 90% of firms appearing before the Commission.
Design Patents
For nearly four decades, Sterne Kessler has been at the forefront of design patents, consistently delivering successful outcomes for clients in securing and defending their design rights. We develop effective, comprehensive IP programs to protect some of the most iconic product designs in the world and to eliminate knock-offs in the marketplace.
Featured News
More News & Insights
Sterne Kessler Again Recognized by Chambers USA as the Only Band 1 Firm for Patent Prosecution in Washington, D.C.
Washington, D.C. (June 4, 2026) – Sterne, Kessler, Goldstein & Fox has been recognized as a leading firm by Chambers USA 2026, again earning the only Band 1…
The Cloud, Data Centers, and Your Trade Secrets
Consider a medical-device company that stores trade secrets — its source code, pricing data, and product development files — on a cloud platform. Employees, outside consultants, and AI-enabled…
IP Hot Topic: “Multiple” AIA Petitions: Clarifying the Terminology
The patent bar has been involved in discussions of how to address “multiple” AIA petitions challenging a same patent in view of changes at the Patent Trial and…
AI, Privilege, and Discovery in View of “Heppner” and “Morgan”
As parties and attorneys increasingly use generative artificial intelligence for litigation preparation, federal courts are beginning to wrestle with the significant practical impacts to litigation discovery. Two recent…
When a Startup Really Needs a Formal Opinion of Patent Counsel (and When It Doesn’t)
Startup technology companies often hear—sometimes vaguely, sometimes urgently—that they “need a patent opinion” before launching a product, raising money, or entering the market. In reality, formal opinions of…
A Precedential “Window” Into the Director’s Discretionary Denial Framework in AIA Proceedings
On May 14, 2026, USPTO Director John Squires issued—and designated precedential—a Director decision denying institution of an inter partes review (IPR) in Magnolia Medical Technologies, Inc. v. Kurin,…
Your innovations are worth the best protection
Expertise
Sterne Kessler is a full-service IP firm that delivers innovative solutions tailored to your business and industry.